Plasma signals of lung tumor promotion for molecular cancer prevention
Tej Pandya(CRUK Lung Cancer Centre of Excellence), Richard Gunu(University College London), Clinton H. Durney(Institute of Population and Public Health), Takahiro Karasaki(The Francis Crick Institute), Alexey Zaikin(National Research University Higher School of Economics), Aino‐Maija Leppä(The Francis Crick Institute), Michelle Leung(CRUK Lung Cancer Centre of Excellence), Marcellus Augustine(The Francis Crick Institute), Maria Zagorulya(The Francis Crick Institute), Charlotte Grieco(Royal Marsden NHS Foundation Trust), Huilei Xu(Novartis (Switzerland)), Hana Zahed(Centre international de recherche sur le cancer), Sin Wi Ng(Walter and Eliza Hall Institute of Medical Research), Léa Montégut(Icahn School of Medicine at Mount Sinai), Simon L. Priestnall(Royal Veterinary College), David C. Muller(UNSW Sydney), Usha Menon(University of South Florida), Kerstin Haase(The Francis Crick Institute), Pablo Serrano‐Fernández(Novartis (Switzerland)), Sophia Apostolidou(Institute for Women's Policy Research), Lydia Liu(CRUK Lung Cancer Centre of Excellence), Chrysante S. Iliakis(The Francis Crick Institute), Miriam Mugabo(CRUK Lung Cancer Centre of Excellence), Rachel Scott(CRUK Lung Cancer Centre of Excellence), Anthony Griffen(Albert Einstein College of Medicine), C L Murphy(CRUK Lung Cancer Centre of Excellence), Vernon A. Burk(Johns Hopkins University), K Chan(University of Oxford), Roel C.H. Vermeulen(Utrecht University), Alexandros Hardas(Royal Veterinary College), Oleg Blyuss(Sechenov University), Ekaterina Pazukhina(Queen Mary University of London), Alejandro Suarez-Bonnet(The Francis Crick Institute), Amalie Grenov(The Francis Crick Institute), Rafael Meza(Institute of Population and Public Health), Ami Archer(The Francis Crick Institute), Matthew D. Park(Icahn School of Medicine at Mount Sinai), Tatjana Crnogorac-Jurcevic(Queen Mary University of London), Marc Pelletier(Novartis (United States)), Jincheng Wu(Novartis (United States)), Ulysse Baruchel(CRUK Lung Cancer Centre of Excellence), Alix Le Marois(The Francis Crick Institute), Neil Wright(University of Oxford), Alpkaan Celik(The Francis Crick Institute), Thomas Snoeks(The Francis Crick Institute), Tamara Klockner(The Francis Crick Institute), Hubert Slawinski(The Francis Crick Institute), Stephen Lam(University of British Columbia), Sophia Ward(CRUK Lung Cancer Centre of Excellence), Alejandro Jiménez-Sánchez(University of Cambridge)
Cited by 6
Related Papers
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Probability of Cancer in Pulmonary Nodules Detected on First Screening CT
|New England Journal of Medicine|2013|1.4k
The evolutionary history of 2,658 cancers
|Nature|2020|1.1k